Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrike Höckendorf

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cell Death and Differentiation|September 23, 2018
Necroinflammation emerges as a key regulator of hematopoiesis in health and diseasePhilipp J Jost, Ulrike Höckendorf
Oncogene|January 29, 2022
The BCL-2 family member BOK promotes KRAS-driven lung cancer progression in a p53-dependent mannerAnna-Lena Meinhardt, Enkhtsetseg Munkhbaatar, Ulrike Höckendorf, et al.
Immunity|March 18, 2014
Clec12a is an inhibitory receptor for uric acid crystals that regulates inflammation in response to cell deathKonstantin Neumann, Mercedes Castiñeiras-Vilariño, Ulrike Höckendorf, et al.
Oncotarget|May 1, 2018
Selective inhibition of BCL-2 is a promising target in patients with high-risk myelodysplastic syndromes and adverse mutational profileVeronika Reidel, Johanna Kauschinger, Richard T Hauch, et al.
Experimental Hematology & Oncology|April 25, 2019
Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored doseStefanie Jilg, Richard T Hauch, Johanna Kauschinger, et al.
Journal of Cancer Research and Clinical Oncology|October 16, 2021
Comprehensive characterization of central BCL-2 family members in aberrant eosinophils and their impact on therapeutic strategiesTimo O Odinius, Lars Buschhorn, Celina Wagner, et al.
Cancer Cell|July 15, 2016
RIPK3 Restricts Myeloid Leukemogenesis by Promoting Cell Death and Differentiation of Leukemia Initiating CellsUlrike Höckendorf, Monica Yabal, Tobias Herold, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 17, 2025
Early Detection of Cell Death Using Transmembrane Water Exchange Magnetic Resonance ImagingAthanasia Kaika, Luca Nagel, Ulrike Höckendorf, et al.
European Journal of Haematology|November 24, 2019
Inhibition of PLK1 by capped-dose volasertib exerts substantial efficacy in MDS and sAML while sparing healthy haematopoiesisVeronika Dill, Johanna Kauschinger, Richard T Hauch, et al.
Science Translational Medicine|November 26, 2025
Lymphotoxin alpha eradicates acute myeloid leukemia and simultaneously promotes healthy hematopoiesis in miceUlrike Höckendorf, Sayantanee Dutta, Arnold Kloos, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cell Death and Differentiation|September 23, 2018
Necroinflammation emerges as a key regulator of hematopoiesis in health and diseasePhilipp J Jost, Ulrike Höckendorf
Oncogene|January 29, 2022
The BCL-2 family member BOK promotes KRAS-driven lung cancer progression in a p53-dependent mannerAnna-Lena Meinhardt, Enkhtsetseg Munkhbaatar, Ulrike Höckendorf, et al.
Immunity|March 18, 2014
Clec12a is an inhibitory receptor for uric acid crystals that regulates inflammation in response to cell deathKonstantin Neumann, Mercedes Castiñeiras-Vilariño, Ulrike Höckendorf, et al.
Oncotarget|May 1, 2018
Selective inhibition of BCL-2 is a promising target in patients with high-risk myelodysplastic syndromes and adverse mutational profileVeronika Reidel, Johanna Kauschinger, Richard T Hauch, et al.
Experimental Hematology & Oncology|April 25, 2019
Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored doseStefanie Jilg, Richard T Hauch, Johanna Kauschinger, et al.
Journal of Cancer Research and Clinical Oncology|October 16, 2021
Comprehensive characterization of central BCL-2 family members in aberrant eosinophils and their impact on therapeutic strategiesTimo O Odinius, Lars Buschhorn, Celina Wagner, et al.
Cancer Cell|July 15, 2016
RIPK3 Restricts Myeloid Leukemogenesis by Promoting Cell Death and Differentiation of Leukemia Initiating CellsUlrike Höckendorf, Monica Yabal, Tobias Herold, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 17, 2025
Early Detection of Cell Death Using Transmembrane Water Exchange Magnetic Resonance ImagingAthanasia Kaika, Luca Nagel, Ulrike Höckendorf, et al.
European Journal of Haematology|November 24, 2019
Inhibition of PLK1 by capped-dose volasertib exerts substantial efficacy in MDS and sAML while sparing healthy haematopoiesisVeronika Dill, Johanna Kauschinger, Richard T Hauch, et al.
Science Translational Medicine|November 26, 2025
Lymphotoxin alpha eradicates acute myeloid leukemia and simultaneously promotes healthy hematopoiesis in miceUlrike Höckendorf, Sayantanee Dutta, Arnold Kloos, et al.
Pageof 2